Avanos Medical (AVNS)
(Delayed Data from NYSE)
$22.80 USD
+0.15 (0.66%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $22.81 +0.01 (0.04%) 6:42 PM ET
1-Strong Buy of 5 1
B Value D Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$22.80 USD
+0.15 (0.66%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $22.81 +0.01 (0.04%) 6:42 PM ET
1-Strong Buy of 5 1
B Value D Growth C Momentum C VGM
Zacks News
Avanos (AVNS) Q2 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Avanos (AVNS) second-quarter results benefit from higher revenues, strong segmental performance and expansion in margins.
Avanos Medical (AVNS) Tops Q2 Earnings Estimates
by Zacks Equity Research
Avanos Medical (AVNS) delivered earnings and revenue surprises of 12.00% and -0.27%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Avanos Medical (AVNS) Q2 Earnings Expected to Decline
by Zacks Equity Research
Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Avanos (AVNS) Q1 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Avanos (AVNS) Q1 results benefit from higher revenues, strong segmental performance and expansion in margins.
Avanos Medical (AVNS) Misses Q1 Earnings Estimates
by Zacks Equity Research
Avanos Medical (AVNS) delivered earnings and revenue surprises of -11.76% and 0.03%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Avanos Medical (AVNS) Q1 Earnings Expected to Decline
by Zacks Equity Research
Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Avanos Medical (AVNS) Q1 Earnings Expected to Decline
by Zacks Equity Research
Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Avanos (AVNS) Q4 Earnings Beat, Revenues Miss, Shares Down
by Zacks Equity Research
Avanos (AVNS) registers solid growth in the Chronic Care and Pain Management segments in Q4.
Avanos Medical (AVNS) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Avanos Medical (AVNS) delivered earnings and revenue surprises of 27.59% and -0.60%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Avanos Medical (AVNS) Q3 Earnings Expected to Decline
by Zacks Equity Research
Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Avanos Medical (AVNS) Jumps: Stock Rises 5.5%
by Zacks Equity Research
Avanos Medical (AVNS) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Avanos Medical (AVNS) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Avanos Medical (AVNS) delivered earnings and revenue surprises of 26.32% and 2.25%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?